Toxic epidermal necrolysis and graft vs. host disease: A clinical spectrum but a diagnostic dilemma

Clinical and Experimental Dermatology

Volumn 24, Issue 4, 1999, Pages 260-262

  Stone, N ^a,b   Sheerin, S ^a   Burge, S ^a  

^a STOKE MANDEVILLE HOSPITAL   (United Kingdom)

^b Department of Dermatology ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTOSINE; DOXORUBICIN; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ADULT; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; DRUG INDUCED DISEASE; GRAFT VERSUS HOST REACTION; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTIPLE ORGAN FAILURE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN MANIFESTATION; SUBCUTANEOUS DRUG ADMINISTRATION; TOXIC EPIDERMAL NECROLYSIS;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW DISEASES; DIAGNOSIS, DIFFERENTIAL; DIARRHEA; EPIDERMAL NECROLYSIS, TOXIC; FATAL OUTCOME; FEVER; GRAFT VS HOST DISEASE; HUMANS; KIDNEY FAILURE; LIVER FAILURE; LYMPHOMA, B-CELL; LYMPHOMA, LYMPHOBLASTIC; MALE; METHOTREXATE; MIDDLE AGED; PLATELET TRANSFUSION;

EID: 0032769177     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.1999.00473.x     Document Type: Article

References (9)

1. 1 Parkes I, Zaki I, Stevens A et al. Graft versus host disease-like eruption in a patient with non-Hodgekins lymphoma. Br J Dermatol 1997; 137: 137-9.
2. 2 Villada G, Roujeau J-C, Cordonnier C et al. Toxic epidermal necrolysis after bone marrow transplantation. J Am Acad Dermatol 1990; 23: 870-5.
3. 3 Nestel F, Price K, Seemayer T, Lapp W. Macrophage priming and lipopolysaccharide triggered release of TNF alpha during graft versus host disease. J Exp Med 1992; 175: 405-13.
4. 4 Paquet P, Nikkels A, Arrese J et al. Macrophages and TNF alpha in toxic epidermal necrolysis. Arch Dermatol 1994; 130: 605-8.
5. 5 Gilliam AC, Whitaker-Menezes D, Korngold R, Murfey GF. Apoptosis is the predominant form of epithelial target cell injury in acute experimental graft versus host disease. J Inv Dermatol 1996; 107: 377-83.
6. 6 Paul C, Wolkenstein P, Adle H et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 1996; 134: 710-4.
7. 7 Aractingi S, Briant E, Marolleau JP et al. Methotrexate-induced skin detachment. Presse Med 1992; 21: 1668-70.
8. 8 Lawrence CM, Dahl MG. Two patterns of skin ulceration induced by methotrexate in patients with psoriasis. J Am Acad Dermatol 1984; 11: 1059-65.
9. 9 Collins P, Rogers S. The efficacy of methotrexate in psoriasis -a review of 40 cases. Clin Exp Dermatol 1992; 17: 257-60.